Global Placenta Market Projected to Reach $275.18 Billion by 2034

The global placenta market is poised for significant expansion over the next decade, with projections indicating a value of $275.18 billion by 2034. According to analysis by Maximize Market Research, the market stood at $96.1 billion in 2025 and is expected to grow at a compound annual growth rate (CAGR) of 12.4% from 2026 to 2034.

The market's growth is underpinned by the increasing integration of placenta-derived ingredients into cosmetics, pharmaceuticals, and dietary supplements. Rising consumer interest in specialized skincare and wellness products, coupled with expanding research into the functional properties of placenta extracts, is fueling this trend. The cosmetics segment, in particular, is identified as a high-potential area, with placenta extracts being incorporated into a variety of creams, serums, and other beauty formulations.

Advancements in placenta extraction and formulation technologies, alongside the development of bioactive ingredients, are creating new market opportunities. Product development, tailored formulations, and the expanding application of placenta-based products across North America, Europe, the Asia-Pacific region, the Middle East & Africa, and South America are expected to shape market dynamics through 2034.

The Asia-Pacific region currently leads the global placenta market, driven by robust research and development activities in countries like Japan, South Korea, and China. North America and Europe also present significant market opportunities. While porcine placenta remains a key source, equine, ovine, and other sources contribute to a diversified product landscape across pharmaceutical, cosmetic, and dietary supplement applications.